Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5932
    -0.0002 (-0.04%)
     
  • NZD/EUR

    0.5543
    +0.0002 (+0.05%)
     
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.54
    -0.82 (-0.98%)
     
  • GOLD

    2,340.80
    -1.30 (-0.06%)
     
  • NASDAQ

    17,493.26
    +21.79 (+0.12%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,412.34
    -91.35 (-0.24%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • NZD/JPY

    91.9300
    +0.1640 (+0.18%)
     

Amgen’s Aimovig is Expected to Witness Steady Growth in 2018

Amgen’s Aimovig is Expected to Witness Steady Growth in 2018

How Is Amgen Positioned for 2018?